Two novel CYP7B1 mutations in Italian families with SPG5: A clinical and genetic study

Dipartimento di Scienze Neurologiche, Università degli Studi di Napoli Federico II, Via Pansini 5, Naples 80131, Italy.
Journal of Neurology (Impact Factor: 3.38). 05/2009; 256(8):1252-7. DOI: 10.1007/s00415-009-5109-3
Source: PubMed


Hereditary spastic paraplegias (HSPs) are a heterogeneous group of neurodegenerative disorders characterized by progressive weakness and spasticity in the lower limbs. Spasticity may occur in isolation (''pure'' HSP) or may be accompanied by other features. Although autosomal recessive HSPs usually have clinically complex phenotypes, mutations within a few genes underlie pure forms. Recently the gene (CYP7B1) responsible for SPG5, a pure recessive HSP, has been identified. The six CYP7B1 coding exons were analysed in four Italian families. Complete clinical assessment was performed in all patients. Blood CYP7B1 mRNA levels were assessed in three patients and six controls. Brain MRI and (18)F-fluoro-deoxy-glucose positron emission tomography (PET) scan were conducted in three patients. Two novel homozygous mutations were identified. Both result in a frameshift and the introduction of a premature stop codon at the C-terminal of the protein. Patients have reduced blood CYP7B1 mRNA levels, suggesting nonsense mediated RNA decay. Although clinical assessment showed a pure form of spastic paraplegia, MRI demonstrated white matter abnormalities in three patients and PET scan revealed cerebellar hypometabolism in one. Based on the results, we report the first Italian families with SPG5 molecular characterization and describe two novel truncating mutations in CYP7B1. The recessive character, the truncating nature of the mutations, and the reduced peripheral blood CYP7B1 mRNA levels suggest that the development of the disease is associated with a loss of function. SPG5 is considered a pure form of HSP, but MRI and PET findings in our patients suggest that SPG5 phenotype may be broader than the pure presentation.

Download full-text


Available from: Elena Salvatore, Jun 10, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Line width control is a key factor in LSI manufacturing. This paper describes the relationship between line width uniformity and the illumination system of an exposure tool. Variation in the local value of partial coherence a is the cause of the optical proximity effect (OPE) variation across the image field of an exposure tool. By quantifying partial coherence σ and decreasing a variation, OPE variation within the image field was improved from 21.2 nm to 8.8 nm. We reduced OPE variation among tools by setting up these tools with agreeing a values. This paper also discusses the effect of illumination source uniformity on line width. Nonuniformity of an illumination source induces a line width difference between pair lines. We improved the treatment for these problems by adjusting the illumination source uniformity
    No preview · Conference Paper · Feb 2001

  • No preview · Article · Jul 2009 · Neuromuscular Disorders
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cholesterol is an essential component of both the peripheral and central nervous systems of mammals. Over the last decade, evidence has accumulated that disturbances in cholesterol metabolism are associated with the development of various neurological conditions. In addition to genetically defined defects in cholesterol synthesis, which will be covered in another review in this Thematic Series, defects in cholesterol metabolism (cerebrotendinous xanthomatosis) and intracellular transport (Niemann Pick Syndrome) lead to neurological disease. A subform of hereditary spastic paresis (type SPG5) and Huntington's disease are neurological diseases with mutations in genes that are of importance for cholesterol metabolism. Neurodegeneration is generally associated with disturbances in cholesterol metabolism, and presence of the E4 isoform of the cholesterol transporter apolipoprotein E as well as hypercholesterolemia are important risk factors for development of Alzheimer's disease. In the present review, we discuss the links between genetic disturbances in cholesterol metabolism and the above neurological disorders.
    Full-text · Article · May 2010 · The Journal of Lipid Research
Show more